1-16 of 16
Olivier Delattre
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy

Open Access
Charles Bobin, Yasmine Iddir, Charlotte Butterworth, Julien Masliah-Planchon, Alexandra Saint-Charles, Angela Bellini, Jaydutt Bhalshankar, Gaelle Pierron, Valérie Combaret, Valéry Attignon, Nicolas André, Nadège Corradini, Benoit Dumont, Ludovic Mansuy, Camille Khanfar, Sebastien Klein, Claire Briandet, Dominique Plantaz, Frederic Millot, Sandrine Thouvenin, Isabelle Aerts, Lee Aymar Ndounga-Diakou, Salim Laghouati, Samuel Abbou, Nina Jehanno, Hubert Tissot, Shufang Renault, Sylvain Baulande, Virginie Raynal, Laurence Bozec, Ivan Bieche, Olivier Delattre, Pablo Berlanga, Gudrun Schleiermacher
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (15): 3316–3328.
https://doi.org/10.1158/1078-0432.CCR-24-0753
Published: 01 August 2024
View articletitled, Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy
Open the PDF for Sequential Analysis of cfDNA Reveals Clonal Evolution in Patients with Neuroblastoma Receiving ALK-Targeted Therapy in another window
Includes: Supplementary data
Journal Articles

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Open Access
Elizabeth R. Tucker, Irene Jiménez, Lindi Chen, Angela Bellini, Chiara Gorrini, Elizabeth Calton, Qiong Gao, Harvey Che, Evon Poon, Yann Jamin, Barbara Martins Da Costa, Karen Barker, Sumana Shrestha, J. Ciaran Hutchinson, Simran Dhariwal, Angharad Goodman, Elaine Del Nery, Pierre Gestraud, Jaydutt Bhalshankar, Yasmine Iddir, Elnaz Saberi-Ansari, Alexandra Saint-Charles, Birgit Geoerger, Maria Eugénia Marques Da Costa, Cécile Pierre-Eugène, Isabelle Janoueix-Lerosey, Didier Decaudin, Fariba Nemati, Angel M. Carcaboso, Didier Surdez, Olivier Delattre, Sally L. George, Louis Chesler, Deborah A. Tweddle, Gudrun Schleiermacher
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (7): 1317–1331.
https://doi.org/10.1158/1078-0432.CCR-22-2274
Published: 03 April 2023
View articletitled, Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Open the PDF for Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models in another window
Includes: Supplementary data
Journal Articles

Abstract IA009: Oncogenic transcription factors drive highly tumor-specific LincRNA

Free
Olivier Delattre, Julien Vibert, Olivier Saulnier, Joshua Waterfall
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (18_Supplement): IA009.
https://doi.org/10.1158/1557-3265.SARCOMAS22-IA009
Published: 15 September 2022
View articletitled, Abstract IA009: Oncogenic transcription factors drive highly tumor-specific LincRNA
Journal Articles

Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma

Free
Mathieu Chicard, Leo Colmet-Daage, Nathalie Clement, Adrien Danzon, Mylène Bohec, Virginie Bernard, Sylvain Baulande, Angela Bellini, Paul Deveau, Gaëlle Pierron, Eve Lapouble, Isabelle Janoueix-Lerosey, Michel Peuchmaur, Nadège Corradini, Anne Sophie Defachelles, Dominique Valteau-Couanet, Jean Michon, Valérie Combaret, Olivier Delattre, Gudrun Schleiermacher
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (4): 939–949.
https://doi.org/10.1158/1078-0432.CCR-17-1586
Published: 14 February 2018
View articletitled, Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma
Open the PDF for Whole-Exome Sequencing of Cell-Free DNA Reveals Temporo-spatial Heterogeneity and Identifies Treatment-Resistant Clones in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Abstract PR06: Functional genomics of CIC-DUX4 fusions in zebrafish recapitulates the spectrum of human CIC-rearranged cancers

Free
Sarah Watson, Genevieve C. Kendall, Whitney A. Murchison, Olivier Delattre, Franck Tirode, James F. Amatruda
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (2_Supplement): PR06.
https://doi.org/10.1158/1557-3265.SARCOMAS17-PR06
Published: 15 January 2018
View articletitled, Abstract PR06: Functional genomics of CIC-DUX4 fusions in zebrafish recapitulates the spectrum of human CIC-rearranged cancers
Journal Articles

Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma

Free
Mathieu Chicard, Sandrine Boyault, Leo Colmet Daage, Wilfrid Richer, David Gentien, Gaelle Pierron, Eve Lapouble, Angela Bellini, Nathalie Clement, Isabelle Iacono, Stéphanie Bréjon, Marjorie Carrere, Cécile Reyes, Toby Hocking, Virginie Bernard, Michel Peuchmaur, Nadège Corradini, Cécile Faure-Conter, Carole Coze, Dominique Plantaz, Anne Sophie Defachelles, Estelle Thebaud, Marion Gambart, Frédéric Millot, Dominique Valteau-Couanet, Jean Michon, Alain Puisieux, Olivier Delattre, Valérie Combaret, Gudrun Schleiermacher
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (22): 5564–5573.
https://doi.org/10.1158/1078-0432.CCR-16-0500
Published: 14 November 2016
View articletitled, Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma
Open the PDF for Genomic Copy Number Profiling Using Circulating Free Tumor DNA Highlights Heterogeneity in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis

Free
Angela Bellini, Virginie Bernard, Quentin Leroy, Thomas Rio Frio, Gaelle Pierron, Valérie Combaret, Eve Lapouble, Nathalie Clement, Herve Rubie, Estelle Thebaud, Pascal Chastagner, Anne Sophie Defachelles, Christophe Bergeron, Nimrod Buchbinder, Sophie Taque, Anne Auvrignon, Dominique Valteau-Couanet, Jean Michon, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2015) 21 (21): 4913–4921.
https://doi.org/10.1158/1078-0432.CCR-15-0423
Published: 01 November 2015
View articletitled, Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis
Open the PDF for Deep Sequencing Reveals Occurrence of Subclonal ALK Mutations in Neuroblastoma at Diagnosis in another window
Includes: Supplementary data
Journal Articles

Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment

Available to Purchase
Irina Lambertz, Candy Kumps, Shana Claeys, Sven Lindner, Anneleen Beckers, Els Janssens, Daniel R. Carter, Alex Cazes, Belamy B. Cheung, Marilena De Mariano, An De Bondt, Sara De Brouwer, Olivier Delattre, Jay Gibbons, Isabelle Janoueix-Lerosey, Geneviève Laureys, Chris Liang, Glenn M. Marchall, Michael Porcu, Junko Takita, David Camacho Trujillo, Ilse Van Den Wyngaert, Nadine Van Roy, Alan Van Goethem, Tom Van Maerken, Piotr Zabrocki, Jan Cools, Johannes H. Schulte, Jorge Vialard, Frank Speleman, Katleen De Preter
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (14): 3327–3339.
https://doi.org/10.1158/1078-0432.CCR-14-2024
Published: 14 July 2015
View articletitled, Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment
Open the PDF for Upregulation of MAPK Negative Feedback Regulators and RET in Mutant ALK Neuroblastoma: Implications for Targeted Treatment in another window
Includes: Supplementary data
Journal Articles

Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers

Available to Purchase
André Oberthuer, Dilafruz Juraeva, Barbara Hero, Ruth Volland, Carolina Sterz, Rene Schmidt, Andreas Faldum, Yvonne Kahlert, Anne Engesser, Shahab Asgharzadeh, Robert Seeger, Miki Ohira, Akira Nakagawara, Paola Scaruffi, Gian Paolo Tonini, Isabelle Janoueix-Lerosey, Olivier Delattre, Gudrun Schleiermacher, Jo Vandesompele, Frank Speleman, Rosa Noguera, Marta Piqueras, Jean Bénard, Alexander Valent, Smadar Avigad, Isaac Yaniv, Richard G. Grundy, Monika Ortmann, Chunxuan Shao, Manfred Schwab, Roland Eils, Thorsten Simon, Jessica Theissen, Frank Berthold, Frank Westermann, Benedikt Brors, Matthias Fischer
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (8): 1904–1915.
https://doi.org/10.1158/1078-0432.CCR-14-0817
Published: 14 April 2015
View articletitled, Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers
Open the PDF for Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers in another window
Includes: Supplementary data
Journal Articles

Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor

Available to Purchase
Franck Bourdeaut, Delphine Lequin, Laurence Brugières, Stéphanie Reynaud, Christelle Dufour, François Doz, Nicolas André, Jean-Louis Stephan, Yves Pérel, Odile Oberlin, Daniel Orbach, Christophe Bergeron, Xavier Rialland, Paul Fréneaux, Dominique Ranchere, Dominique Figarella-Branger, Georges Audry, Stéphanie Puget, D. Gareth Evans, Joan Carles Ferreres Pinas, Valeria Capra, Véronique Mosseri, Isabelle Coupier, Marion Gauthier-Villars, Gaëlle Pierron, Olivier Delattre
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (1): 31–38.
https://doi.org/10.1158/1078-0432.CCR-10-1795
Published: 04 January 2011
View articletitled, Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
Open the PDF for Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor in another window
Includes: Supplementary data
Journal Articles

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Available to Purchase
Sara De Brouwer, Katleen De Preter, Candy Kumps, Piotr Zabrocki, Michaël Porcu, Ellen M. Westerhout, Arjan Lakeman, Jo Vandesompele, Jasmien Hoebeeck, Tom Van Maerken, Anne De Paepe, Geneviève Laureys, Johannes H. Schulte, Alexander Schramm, Caroline Van Den Broecke, Joëlle Vermeulen, Nadine Van Roy, Klaus Beiske, Marleen Renard, Rosa Noguera, Olivier Delattre, Isabelle Janoueix-Lerosey, Per Kogner, Tommy Martinsson, Akira Nakagawara, Miki Ohira, Huib Caron, Angelika Eggert, Jan Cools, Rogier Versteeg, Frank Speleman
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (17): 4353–4362.
https://doi.org/10.1158/1078-0432.CCR-09-2660
Published: 31 August 2010
View articletitled, Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification
Open the PDF for Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification in another window
Includes: Supplementary data
Journal Articles

Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival

Available to Purchase
Gaëlle Picarda, François Lamoureux, Loïc Geffroy, Pascal Delepine, Tristan Montier, Karine Laud, Franck Tirode, Olivier Delattre, Dominique Heymann, Françoise Rédini
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (8): 2363–2374.
https://doi.org/10.1158/1078-0432.CCR-09-1779
Published: 14 April 2010
View articletitled, Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival
Open the PDF for Preclinical Evidence that Use of TRAIL in Ewing's Sarcoma and Osteosarcoma Therapy Inhibits Tumor Growth, Prevents Osteolysis, and Increases Animal Survival in another window
Journal Articles

Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature

Available to Purchase
Katleen De Preter, Joëlle Vermeulen, Benedikt Brors, Olivier Delattre, Angelika Eggert, Matthias Fischer, Isabelle Janoueix-Lerosey, Cinzia Lavarino, John M. Maris, Jaume Mora, Akira Nakagawara, André Oberthuer, Miki Ohira, Gudrun Schleiermacher, Alexander Schramm, Johannes H. Schulte, Qun Wang, Frank Westermann, Frank Speleman, Jo Vandesompele
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (5): 1532–1541.
https://doi.org/10.1158/1078-0432.CCR-09-2607
Published: 28 February 2010
View articletitled, Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature
Open the PDF for Accurate Outcome Prediction in Neuroblastoma across Independent Data Sets Using a Multigene Signature in another window
Includes: Supplementary data
Journal Articles

Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration

Available to Purchase
Ana S. Guerreiro, Sarah Fattet, Barbara Fischer, Tarek Shalaby, Shaun P. Jackson, Simone M. Schoenwaelder, Michael A. Grotzer, Olivier Delattre, Alexandre Arcaro
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (21): 6761–6769.
https://doi.org/10.1158/1078-0432.CCR-08-0385
Published: 03 November 2008
View articletitled, Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration
Open the PDF for Targeting the PI3K p110α Isoform Inhibits Medulloblastoma Proliferation, Chemoresistance, and Migration in another window
Journal Articles

Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast

Available to Purchase
Anne Vincent-Salomon, Carlo Lucchesi, Nadège Gruel, Virginie Raynal, Gaëlle Pierron, Rémi Goudefroye, Fabien Reyal, François Radvanyi, Rémy Salmon, Jean-Paul Thiery, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Alain Fourquet, Olivier Delattre, for the breast cancer study group of the Institut Curie
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (7): 1956–1965.
https://doi.org/10.1158/1078-0432.CCR-07-1465
Published: 01 April 2008
View articletitled, Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast
Open the PDF for Integrated Genomic and Transcriptomic Analysis of Ductal Carcinoma In situ of the Breast in another window
Includes: Supplementary data
Journal Articles

A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

Available to Purchase
Elisabetta Marangoni, Anne Vincent-Salomon, Nathalie Auger, Armelle Degeorges, Franck Assayag, Patricia de Cremoux, Ludmilla de Plater, Charlotte Guyader, Gonzague De Pinieux, Jean-Gabriel Judde, Magali Rebucci, Carine Tran-Perennou, Xavier Sastre-Garau, Brigitte Sigal-Zafrani, Olivier Delattre, Véronique Diéras, Marie-France Poupon
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3989–3998.
https://doi.org/10.1158/1078-0432.CCR-07-0078
Published: 02 July 2007
View articletitled, A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays
Open the PDF for A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays in another window